• C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in...
    39 KB (3,271 words) - 14:51, 19 April 2024
  • Thumbnail for Boehringer Ingelheim Animal Health
    Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and...
    7 KB (655 words) - 05:48, 7 April 2024
  • Thumbnail for Ingelheim am Rhein
    Mainz-Bingen. Furthermore, Ingelheim harbours the business Boehringer Ingelheim which is active worldwide. In 2004, 36% of Ingelheim's inhabitants belonged...
    36 KB (3,515 words) - 09:52, 6 January 2024
  • Thumbnail for Biberach an der Riß
    January, 2022. Boehringer Ingelheim researches, develops and produces pharmaceuticals. Boehringer Ingelheim was founded in Ingelheim am Rhein, Germany...
    13 KB (1,094 words) - 11:49, 13 October 2023
  • Boehringer (Böhringer) may refer to: Boehringer Ingelheim, a pharmaceutical company Boehringer Laboratories, an American medical technology company Boehringer...
    760 bytes (106 words) - 22:05, 7 February 2024
  • [dead link] "Boehringer Ingelheim Financial Highlights 2023". "Boehringer Ingelheim Financial Report 2022" (PDF). "Boehringer Ingelheim Summary Report...
    61 KB (2,701 words) - 11:52, 23 April 2024
  • Thumbnail for Bromhexine
    excessive mucus. It was developed in the research laboratory of Boehringer Ingelheim in the late 1950s as an active ingredient for pharmaceutical use...
    4 KB (298 words) - 21:33, 4 February 2024
  • Hubertus von Baumbach (category Boehringer Ingelheim people)
    chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company. The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von...
    6 KB (434 words) - 13:12, 23 December 2023
  • {h}}]}{{\text{output per step}}[{\ce {kg}}]}}} The process chemistry group at Boehringer Ingelheim, for example, targets a VTO of less than 1 for any given synthetic...
    31 KB (4,405 words) - 05:18, 27 December 2023
  • Thumbnail for Methylenedioxypyrovalerone
    inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. Its activity at the dopamine transporter is six times stronger than...
    33 KB (3,298 words) - 12:49, 4 April 2024
  • Thumbnail for Ponazuril
    Ponazuril (INN), sold by Merial, Inc., now part of Boehringer Ingelheim, under the trade name Marquis® (15% w/w ponazuril), is a drug currently approved...
    4 KB (170 words) - 01:14, 11 October 2023
  • Thumbnail for Meloxicam
    Meloxicam (category Drugs developed by Boehringer Ingelheim)
    for medical use in the United States in 2000. It was developed by Boehringer Ingelheim; however, it is also available as a generic medication. In 2021,...
    39 KB (3,733 words) - 03:47, 4 May 2024
  • Thumbnail for Nebulizer
    the biggest draw back of the jet nebulizer. The medical company Boehringer Ingelheim also invented a device named Respimat Soft Mist Inhaler in 1997....
    24 KB (2,790 words) - 13:17, 7 May 2024
  • Thumbnail for Kobe
    in the city, including Eli Lilly and Company, Procter & Gamble, Boehringer Ingelheim, and Nestlé. The city is the point of origin and namesake of Kobe...
    63 KB (4,712 words) - 10:20, 1 May 2024
  • Thumbnail for Heinrich Otto Wieland
    Heinrich Otto Wieland (category Boehringer Ingelheim people)
    teach at the university and starting in 1907 was a consultant for Boehringer Ingelheim.[citation needed] In 1914 he became associate professor for special...
    8 KB (706 words) - 02:39, 9 January 2024
  • Thumbnail for Eli Lilly and Company
    while Boehringer Ingelheim could receive more than $800 million from development of the new drugs. Oral anti-diabetic of Boehringer Ingelheim–Linagliptin...
    164 KB (15,128 words) - 23:57, 28 April 2024
  • Thumbnail for Metformin
    Metformin (category Drugs developed by Boehringer Ingelheim)
    Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in...
    142 KB (13,772 words) - 06:08, 27 April 2024
  • Johannes Gutenberg University in Mainz, Germany. It is funded by the Boehringer Ingelheim Foundation and the state of Rheinland Palatinate. The scientists...
    15 KB (1,468 words) - 23:20, 30 December 2023
  • Survodutide (category Drugs developed by Boehringer Ingelheim)
    analog rather than an analog of oxyntomodulin. It is developed by Boehringer Ingelheim as a weight loss drug. Klein, Thomas; Augustin, Robert; Hennige,...
    7 KB (207 words) - 02:30, 9 February 2024
  • United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. Of the gliflozins, empagliflozin and tofogliflozin have the highest...
    44 KB (4,552 words) - 03:39, 6 May 2024
  • Thumbnail for Respimat
    disease (COPD), and other respiratory conditions. Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety...
    1 KB (93 words) - 18:59, 24 August 2022
  • Thumbnail for Nintedanib
    Nintedanib (category Drugs developed by Boehringer Ingelheim)
    and platelet derived growth factor receptor. Ofev was developed by Boehringer Ingelheim. It received U.S. Food and Drug Administration (FDA) approval for...
    34 KB (3,010 words) - 06:21, 10 April 2024
  • Empagliflozin (category Drugs developed by Boehringer Ingelheim)
    SGLT-2 over SGLT-1, SGLT-4, SGLT-5 and SGLT-6. It was developed by Boehringer Ingelheim and is co-marketed by Eli Lilly and Company. It is also available...
    38 KB (3,321 words) - 03:33, 12 May 2024
  • Torosyan v. Boehringer Ingelheim Pharmaceuticals, Inc., 662 A2d 89 (1995) is a US labor law case, concerning the contract of employment in state law for...
    1 KB (148 words) - 15:51, 11 March 2024
  • Thumbnail for Clonidine
    Clonidine (category Drugs developed by Boehringer Ingelheim)
    "CATAPRES® 150 TABLETS CATAPRES® AMPOULES" (PDF). TGA eBusiness Services. Boehringer Ingelheim Pty Limited. 28 February 2013. Archived from the original on 16 January...
    60 KB (5,498 words) - 20:48, 12 April 2024
  • Thumbnail for Olodaterol
    Olodaterol (category Drugs developed by Boehringer Ingelheim)
    chronic obstructive pulmonary disease (COPD). It is manufactured by Boehringer Ingelheim. Olodaterol is a once-daily maintenance bronchodilator treatment...
    10 KB (834 words) - 22:16, 4 March 2024
  • Thumbnail for Fenoterol
    bronchodilator asthma medication. Fenoterol is produced and sold by Boehringer Ingelheim as Berotec N and in combination with ipratropium as Berodual N. It...
    10 KB (790 words) - 20:59, 10 March 2024
  • Thumbnail for Centalun
    Centalun was developed by Boehringer Ingelheim in 1962 and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA...
    3 KB (178 words) - 09:42, 30 January 2023
  • Thumbnail for Dabigatran
    Dabigatran (category Drugs developed by Boehringer Ingelheim)
    July 2014, a series of investigations accused the privately held Boehringer Ingelheim pharmaceutical group of withholding critical information about the...
    40 KB (3,517 words) - 07:14, 11 May 2024
  • Thumbnail for Ingelheim Imperial Palace
    Kaiserpfalz Ingelheim. In: Archäologie in Rheinland-Pfalz. ISSN 1614-4627 François Lachenal, Robert Boehringer (Hrsg.) (1974). Ingelheim am Rhein. 774–1974...
    10 KB (1,356 words) - 03:39, 20 January 2024